1401967-20-1Relevant articles and documents
Cyclopropylamines as LSD1 inhibitors
-
Page/Page column 83; 84, (2016/06/14)
This invention relates to the use of cyclopropylamine derivatives for the modulation, notably the inhibition of the activity of Lysine-specific demethylase 1 (LSD1). Suitably, the present invention relates to the use of cyclopropylamines in the treatment of cancer.
LSD1 Fluorocyclopropylamine as inhibitor
-
Paragraph 0252, (2016/10/09)
This invention relates to the use of cyclopropylamine derivatives for the modulation, notably the inhibition of the activity of Lysine-specific demethylase 1 (LSD1). Suitably, the present invention relates to the use of cyclopropylamines in the treatment of cancer.